Investor optimism has waned as final minutes from uniQure’s pre-BLA meeting with the FDA convey that data from the company’s ...

Oliver has an inherited condition called Hunter syndrome, which causes progressive damage to the body and brain.

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...

Operational real-world data analyzed from patients prescribed ZYNTEGLO™ and LYFGENIA™Data demonstrates the value proposition of one-time, durable gene therapy for the treatment of sickle cell disease ...

Please refer to the ASH 2025 online program for full session details and visit the Genetix booth (#1261) onsite.

Treating our first patient is a proud moment for Abeona and a testament to the tireless resolve of our team,” said Vish ...

2025 FEB 06 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Daily News-- Researchers detail new data in Biotechnology - Gene Therapy. According to news reporting originating in Boston ...

The CVCT Forum is an annual, invite-only workshop that aims to cultivate a multi-stakeholder exchange to enhance clinical trials, streamline regulatory approval processes, and facilitate the ...

The cell and gene therapy (CGT) sector is undergoing a transition as companies navigate a more selective and strategy-driven ...

Wondering if Bio-Techne at around $60 a share is a bargain in disguise or a value trap? This breakdown will walk you through what the numbers are really saying about the stock. Despite being down ...

Biotechs in the charter city of Próspera aim to cure ageing, but experts question the feasibility of their goals.